ASX - By Stock
|
LYC |
Re:
Ann: Lynas Appeals Malaysian Licence Conditions
|
|
asanque
|
128 |
59K |
8 |
16/02/23 |
16/02/23 |
ASX - By Stock
|
128
|
59K
|
8
|
|
ASX - By Stock
|
LYC |
Re:
Ann: Lynas Appeals Malaysian Licence Conditions
|
|
asanque
|
128 |
59K |
16 |
16/02/23 |
16/02/23 |
ASX - By Stock
|
128
|
59K
|
16
|
|
ASX - By Stock
|
LYC |
Re:
News: LYC UPDATE 1-Malaysia says Lynas' license could be revoked if it fails to comply with curbs
|
|
asanque
|
56 |
19K |
9 |
16/02/23 |
16/02/23 |
ASX - By Stock
|
56
|
19K
|
9
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Adjournment of Scheme Meeting to a date to be determined
|
|
asanque
|
193 |
56K |
6 |
25/08/22 |
25/08/22 |
ASX - By Stock
|
193
|
56K
|
6
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Correction to ASX announcement
|
|
asanque
|
70 |
21K |
13 |
22/08/22 |
22/08/22 |
ASX - By Stock
|
70
|
21K
|
13
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Best and Final Confirmation and Bridging Loan
|
|
asanque
|
242 |
68K |
14 |
16/08/22 |
16/08/22 |
ASX - By Stock
|
242
|
68K
|
14
|
|
ASX - By Stock
|
RAP |
Re:
Offer Increase 21c Vote Yes
|
|
asanque
|
252 |
74K |
9 |
03/08/22 |
03/08/22 |
ASX - By Stock
|
252
|
74K
|
9
|
|
ASX - By Stock
|
RAP |
Re:
HOW TO VOTE
|
|
asanque
|
123 |
37K |
21 |
25/07/22 |
25/07/22 |
ASX - By Stock
|
123
|
37K
|
21
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp receives FDA 510(k) clearance for SleepCheckRx
|
|
asanque
|
126 |
38K |
23 |
06/07/22 |
06/07/22 |
ASX - By Stock
|
126
|
38K
|
23
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Scheme Update
|
|
asanque
|
132 |
47K |
4 |
05/07/22 |
05/07/22 |
ASX - By Stock
|
132
|
47K
|
4
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Scheme Update
|
|
asanque
|
132 |
47K |
21 |
30/06/22 |
30/06/22 |
ASX - By Stock
|
132
|
47K
|
21
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Scheme Update
|
|
asanque
|
132 |
47K |
18 |
30/06/22 |
30/06/22 |
ASX - By Stock
|
132
|
47K
|
18
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Results from Data Confirmation Study
|
|
asanque
|
425 |
129K |
13 |
21/06/22 |
21/06/22 |
ASX - By Stock
|
425
|
129K
|
13
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Investor Webinar
|
|
asanque
|
118 |
39K |
3 |
17/06/22 |
17/06/22 |
ASX - By Stock
|
118
|
39K
|
3
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Investor Webinar
|
|
asanque
|
118 |
39K |
3 |
17/06/22 |
17/06/22 |
ASX - By Stock
|
118
|
39K
|
3
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Investor Webinar
|
|
asanque
|
118 |
39K |
6 |
17/06/22 |
17/06/22 |
ASX - By Stock
|
118
|
39K
|
6
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Investor Webinar
|
|
asanque
|
118 |
39K |
9 |
17/06/22 |
17/06/22 |
ASX - By Stock
|
118
|
39K
|
9
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Investor Webinar
|
|
asanque
|
118 |
39K |
14 |
17/06/22 |
17/06/22 |
ASX - By Stock
|
118
|
39K
|
14
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Investor Webinar
|
|
asanque
|
118 |
39K |
5 |
17/06/22 |
17/06/22 |
ASX - By Stock
|
118
|
39K
|
5
|
|
ASX - By Stock
|
RAP |
Re:
Vote NO Pfizer offer
|
|
asanque
|
555 |
192K |
7 |
16/06/22 |
16/06/22 |
ASX - By Stock
|
555
|
192K
|
7
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Increased Scheme Consideration from Pfizer
|
|
asanque
|
377 |
145K |
2 |
14/06/22 |
14/06/22 |
ASX - By Stock
|
377
|
145K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Suspension from Official Quotation
|
|
asanque
|
128 |
52K |
6 |
06/06/22 |
06/06/22 |
ASX - By Stock
|
128
|
52K
|
6
|
|
ASX - By Stock
|
RAP |
Re:
Valuing ResApp Health
|
|
asanque
|
466 |
165K |
9 |
30/05/22 |
30/05/22 |
ASX - By Stock
|
466
|
165K
|
9
|
|
ASX - By Stock
|
RAP |
Re:
Valuing ResApp Health
|
|
asanque
|
466 |
165K |
14 |
11/05/22 |
11/05/22 |
ASX - By Stock
|
466
|
165K
|
14
|
|
ASX - By Stock
|
RAP |
Re:
Valuing ResApp Health
|
|
asanque
|
466 |
165K |
40 |
11/05/22 |
11/05/22 |
ASX - By Stock
|
466
|
165K
|
40
|
|
ASX - By Stock
|
RAP |
Re:
NO-Vote support statement - draft 3
|
|
asanque
|
32 |
8.1K |
4 |
02/05/22 |
02/05/22 |
ASX - By Stock
|
32
|
8.1K
|
4
|
|
ASX - By Stock
|
RAP |
Re:
Vote NO Pfizer offer
|
|
asanque
|
555 |
192K |
2 |
13/04/22 |
13/04/22 |
ASX - By Stock
|
555
|
192K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Proposed Acquisition of ResApp Health by Pfizer
|
|
asanque
|
687 |
261K |
8 |
11/04/22 |
11/04/22 |
ASX - By Stock
|
687
|
261K
|
8
|
|
ASX - By Stock
|
RAP |
Re:
Covid Data Day
|
|
asanque
|
13 |
4.8K |
0 |
22/03/22 |
22/03/22 |
ASX - By Stock
|
13
|
4.8K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp announces positive results of COVID-19 screening test
|
|
asanque
|
530 |
153K |
4 |
22/03/22 |
22/03/22 |
ASX - By Stock
|
530
|
153K
|
4
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Trading Halt
|
|
asanque
|
213 |
78K |
3 |
22/03/22 |
22/03/22 |
ASX - By Stock
|
213
|
78K
|
3
|
|
ASX - By Stock
|
RAP |
Re:
Ann: First participant recruited in COVID-19 cough study
|
|
asanque
|
42 |
14K |
4 |
17/05/21 |
17/05/21 |
ASX - By Stock
|
42
|
14K
|
4
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
asanque
|
314 |
84K |
2 |
29/01/21 |
29/01/21 |
ASX - By Stock
|
314
|
84K
|
2
|
|
ASX - By Stock
|
LYC |
Re:
Predictions on LYNAS future in malaysia
|
|
asanque
|
10 |
9.9K |
31 |
14/08/19 |
14/08/19 |
ASX - By Stock
|
10
|
9.9K
|
31
|
|
ASX - By Stock
|
LYC |
Re:
dr looi on fb malaysia
|
|
asanque
|
3.3K |
8.0M |
17 |
13/08/19 |
13/08/19 |
ASX - By Stock
|
3.3K
|
8.0M
|
17
|
|
ASX - By Stock
|
LYC |
Re:
PUBLIC HEARING
|
|
asanque
|
23 |
13K |
7 |
11/11/18 |
11/11/18 |
ASX - By Stock
|
23
|
13K
|
7
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Voluntary Suspension
|
|
asanque
|
490 |
245K |
3 |
24/10/18 |
24/10/18 |
ASX - By Stock
|
490
|
245K
|
3
|
|
ASX - By Stock
|
LYC |
Re:
Positive Comments from Yeo!
|
|
asanque
|
18 |
9.9K |
7 |
18/10/18 |
18/10/18 |
ASX - By Stock
|
18
|
9.9K
|
7
|
|
ASX - By Stock
|
LYC |
Re:
Ann: Malaysian Regulatory Update
|
|
asanque
|
112 |
44K |
6 |
17/10/18 |
17/10/18 |
ASX - By Stock
|
112
|
44K
|
6
|
|
ASX - By Stock
|
LYC |
Re:
News: LYC Malaysian deputy minister offers to leave committee reviewing Lynas' rare earth plant
|
|
asanque
|
76 |
36K |
19 |
12/10/18 |
12/10/18 |
ASX - By Stock
|
76
|
36K
|
19
|
|
ASX - By Stock
|
LYC |
Re:
Media Release - Not a good Sign
|
|
asanque
|
454 |
201K |
13 |
12/10/18 |
12/10/18 |
ASX - By Stock
|
454
|
201K
|
13
|
|
ASX - By Stock
|
LYC |
Re:
Media Release - Not a good Sign
|
|
asanque
|
454 |
201K |
13 |
12/10/18 |
12/10/18 |
ASX - By Stock
|
454
|
201K
|
13
|
|
ASX - By Stock
|
LYC |
Re:
Today's chart & trading
|
|
asanque
|
2.2K |
1.0M |
2 |
05/10/18 |
05/10/18 |
ASX - By Stock
|
2.2K
|
1.0M
|
2
|
|
ASX - By Stock
|
LYC |
Re:
Ann: Review of Lynas Operations in Malaysia
|
|
asanque
|
209 |
61K |
23 |
03/10/18 |
03/10/18 |
ASX - By Stock
|
209
|
61K
|
23
|
|
ASX - By Stock
|
LYC |
Re:
Ann: Media Speculation - Review of Lynas in Malaysia
|
|
asanque
|
293 |
133K |
17 |
24/09/18 |
24/09/18 |
ASX - By Stock
|
293
|
133K
|
17
|
|
ASX - By Stock
|
RAP |
Re:
rap chart
|
|
asanque
|
4.6K |
2.2M |
3 |
05/09/18 |
05/09/18 |
ASX - By Stock
|
4.6K
|
2.2M
|
3
|
|
ASX - By Stock
|
RAP |
Re:
Morgan Video A Big Step towards the holy Grail of FDA
|
|
asanque
|
24 |
11K |
0 |
04/09/18 |
04/09/18 |
ASX - By Stock
|
24
|
11K
|
0
|
|
ASX - By Stock
|
PDN |
Re:
Ann: Effectuation of DOCA and Appointment of new Directors
|
|
asanque
|
8 |
5.6K |
6 |
02/02/18 |
02/02/18 |
ASX - By Stock
|
8
|
5.6K
|
6
|
|
ASX - By Stock
|
SGH |
Re:
Maurice and Vannin
|
|
asanque
|
9 |
3.0K |
1 |
21/11/17 |
21/11/17 |
ASX - By Stock
|
9
|
3.0K
|
1
|
|
ASX - By Stock
|
SGH |
Re:
Anyone going to the AGM?
|
|
asanque
|
11 |
3.8K |
3 |
31/10/17 |
31/10/17 |
ASX - By Stock
|
11
|
3.8K
|
3
|
|